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ABSTRACT
Long-term diabetes leads to macrovascular and microvascular complication. In diabetic retinopa-
thy (DR), persistent hyperglycemia causes permanent loss of retinal pericytes and aberrant pro-
liferation of microvascular endothelial cells (ECs). Adipose tissue-derived stromal cells (ASCs)
may serve to functionally replace retinal pericytes and normalize retinal microvasculature during
disease progression. We hypothesized that Notch signaling in ASC underlies regulation and sta-
bilization of dysfunctional retinal microvascular networks such as in DR. ASC prominently and
constitutively expressed NOTCH2. Genetic knockdown of NOTCH2 in ASC (SH-NOTCH2) disturbed
the formation of vascular networks of human umbilical cord vein endothelial cells both on
monolayers of ASC and in organotypical three-dimensional cocultures with ASC. On ASC SH-
NOTCH2, cell surface platelet-derived growth factor receptor beta was downregulated which dis-
rupted their migration toward the chemoattractant platelet-derived growth factor beta subunits
(PDGF-BB) as well as to conditioned media from EC and bovine retinal EC. This chemoattractant
is secreted by pro-angiogenic EC in newly formed microvascular networks to attract pericytes.
Intravitreal injected ASC SH-NOTCH2 in oxygen-induced retinopathy mouse eyes did not engraft
in the preexisting retinal microvasculature. However, the in vivo pro-angiogenic capacity of ASC
SH-NOTCH2 did not differ from controls. In this respect, multifocal electroretinography displayed
similar b-wave amplitudes in the avascular zones when either wild type ASC or SH-NOTCH2 ASC
were injected. In conclusion, our results indicate that NOTCH2 is essential to support in vitro
vasculogenesis via juxtacrine interactions. In contrast, ongoing in vivo angiogenesis is inﬂuenced
by paracrine signaling of ASC, irrespective of Notch signaling. STEM CELLS 2018;36:240–251
SIGNIFICANCE STATEMENT
In this study, NOTCH2 is identified as a novel regulator of pericytic phenotype of human adipose
tissue-derived stromal cells (ASCs). Results show that NOTCH2 modulates (a) ASC migration to
the retinal microenvironment and (b) endothelial cells assembly in a vessel network formation in
vitro. At the molecular level, NOTCH2 promotes the ASC pericytic phenotype through platelet-
derived growth factor receptor beta expression and sensitivity to chemoattractant.
INTRODUCTION
Patients affected by diabetes are at risk for
developing microvascular complications due to
dysregulated glucose metabolism. One of
these complications, namely diabetic retinopa-
thy (DR), weakens the capillaries in the eyes
leading to blindness [1]. At the cellular level,
hyperglycemia (HG) compromises the juxta-
crine interactions between pericytes and
microvascular endothelial cells (EC) which con-
stitute the retinal capillary network [2]. This is
followed by a hypoxia-driven pro-angiogenic
response that causes an increase in retinal
dysfunctional capillaries that lack pericytic cov-
erage. In normal physiology pericytes wrap
around EC, which results in juxtacrine and
paracrine cross-communication between the
cells that establishes the endothelial barrier
and serves to maintain endothelial function [3,
4]. Retinal capillaries have the highest peri-
cytes density in the body; each EC is sup-
ported by one pericyte which emphasizes the
importance of pericytes in the retina. Migra-
tion, differentiation, and stabilization of EC all
highly depend on interactions with pericytes.
Stem cell therapy has been exploited for
replacement of compromised or lost tissue
cells for several decades. Among these thera-
peutically relevant cells mesenchymal stem
cells (MSC), such as adipose tissue-derived
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REGENERATIVE MEDICINE
potency to differentiate into smooth muscle cells and peri-
cytes [6, 7]. Besides this constructive role, ASC are instructive
in regenerative processes and secrete a host of mediators
that favor the formation and maintenance of blood vessels,
that is, vascular endothelial growth factor (VEGF), platelet-
derived growth factor (PDGF), angiopoetins-1 and 2 (Ang-1,
Ang-2) [8–10]. Moreover, ASC promote remodeling of the
extracellular matrix [11, 12], which is essential during vasculo-
genesis. Less well-known is that ASC act in a juxtacrine man-
ner, that is, engaging in cell-to-cell contact with target cells to
inﬂuence their function. In vitro, ASC monolayers induce vas-
cular(-like) network formation (VNF) of EC, thereby creating a
relevant model for investigating the responsible juxtacrine
mediators on ASC [13]. ASC cultured in vitro phenotypically
resemble pericytes and can replace lost pericytes in rodent
models of experimental DR [14]. Importantly, we recently
showed that ASC are resilient to HG in VNF of EC, suggesting
that ASC may be promising for early stage treatment of DR
[15].
An important family of proteins involved in vascular mor-
phogenesis and maintenance is the Notch family [16]. Mam-
mals express four Notch receptors (NOTCH1 to 4) and ﬁve
membrane bound ligands (JAGGED 1–2 and Delta-like 1–3 and
4). After binding to their ligands, Notch receptors are proteo-
lytically activated by a complex of tumor necrosis factor-beta-
converting enzyme (ACE) and gamma-secretase. This releases
the Notch intracellular domain (NICD) which translocates into
the nucleus and binds to C-promoter-binding factor (CBF-1/
RBPJk/Su[H]/Lag-1) and coactivator Mastermind-like (MAML)
and activates the transcription of downstream genes in partic-
ular HEY and HES [17–19]. Furthermore, NICD has been shown
to form complex with endothelial transcription factor (ERG)
and b-catenin, mediating in turn Ang1-dependent delta-like 4
(Dll4)/Notch signaling in EC [20]. The role of Notch signaling
in vascular stability is enhanced by supporting neighboring
cells. For example, activation of smooth muscle genes in bona
ﬁde pericytes, requires interaction with EC by binding of cell
surface NOTCH3 and JAGGED1 [21, 22]. Capillary branching,
differentiation, and patterning processes in the retina depend
on equilibrium between Notch ligands and receptors on adja-
cent cells. Indeed, JAGGED1 is a potent proangiogenic factor
which antagonizes Dll4/Notch signaling on EC during sprouting
angiogenesis. Pericyte recruitment and JAGGED1 expression
results in NOTCH1 upregulation, suppression of tip cells’ DLL4
and reduced stalk cells responsiveness to VEGF-A, ultimately
leading to homeostasis of the capillaries bed [23, 24]. Besides,
Notch signaling activation reduces the volume of age-related
macular degeneration [25]. The latter study highlights the role
of Notch signaling in maintaining the balance between proan-
giogenic genes such as VEGF Receptor 2 (VEGFR2), C-C che-
mokine receptor 3 (CCR3) and PDGF-BB and antiangiogenic
genes such as VEGFR1 and UNC5B.
Much of the action of ASC is achieved by paracrine sig-
naling, yet pericytes and EC also communicate via juxtacrine
signaling. We argued that given the differences in sensitivity
to HG between ASC and bona ﬁde pericytes, juxtacrine sig-
naling will differ too. The current study aims at understand-
ing the role of Notch signaling in the pericytic function of
ASC in vitro and, in a mouse model of pathological
vasoproliferation.
MATERIALS AND METHODS
Primary Cell Cultures and Isolation
ASC were isolated from lipoaspirates as described previously
[26]. Anonymously donated samples were obtained with
informed consent as approved by the ethical board of the
University Medical Center Groningen following the guidelines
for “waste materials.” Propagation of ASC was in Dulbecco’s
modiﬁed eagle’s medium (DMEM) (BioWhittaker, Walkersville,
MD): 10% bovine serum albumin (BSA), 1% l-Glutamine, 1%
Penicillin/Streptomycin (P/S); which was changed for EC
medium (ECM, roswell park memorial institute (RPMI)-1640
(Lonza Biowhittaker Verviers, Belgium), 10% heat inactivated
FBS (Thermo Scientiﬁc, Hemel Hempstead, U.K.), 100 U/ml
penicillin, 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA),
2 mM L-glutamine (Lonza Biowhittaker Verviers, Belgium), 5
U/ml heparin (Leo Pharma, The Netherlands), and 5 mg/ml of
EC growth factor) prior to coculture experiments. Human
umbilical cord vein endothelial cells (HUVEC) were obtained
from Lonza (Breda, The Netherlands) and the Endothelial Cell
Facility of University Medical Center Groningen, The Nether-
lands. ASC and HUVEC were seeded at 4 3 104/cm2. HUVEC
were cultured on gelatin-coated tissue culture polystyrene.
Bovine retinal endothelial cells (BREC) were isolated from reti-
nas of bovine eyes purchased at the local slaughter house
[27]. Upon receipt the eyes were brieﬂy immersed in 70%
ethanol for sterilization purposes. The retinas were harvested
from the eyes (approximately 80 eyes per isolation) and
washed in DMEM. Subsequently, the retinas were minced in
small pieces and incubated with an enzyme cocktail: collage-
nase type 4 (500 mg/ml, Thermo Fisher Scientiﬁc, MA), DNase
(200 mg/ml, Roche Diagnostic, Mannheim, Germany) and, pro-
nase E (200 mg/ml, Roche Diagnostic, Mannheim, Germany) at
378C for 30 minutes. The digested retinas were ﬁltered
through a 53 mm mesh nylon ﬁlter and the cell homogenate
seeded on gelatin coated plates in DMEM (BioWhittaker, Wal-
kersville, MD): 10% FBS, 1% l-Glutamine, 1% Penicillin/Strepto-
mycin (P/S). Cells’ medium was refreshed every 3 days. ASC
and HUVEC were used between passage 3 and 5. BREC pas-
saged twice were used for downstream applications.
Gene Transcript Analysis
The gene expression proﬁles of Notch members were ana-
lyzed in ASC and HUVEC or BREC. Total RNA was extracted
using Trizol Reagent (Life technologies, Carlsbad, CA) accord-
ing to the manufacturer’s protocol. Afterward, 1 mg of total
RNA was reverse transcribed using the First Strand cDNA syn-
thesis kit (Fermentas UAB, Vilnius, Lithuania) according to the
manufacturer’s instructions. The cDNA equivalent of 5 ng RNA
was used for ampliﬁcation in 384-well microtiter plates in a
TaqMAN ABI7900HT cycler (Applied Biosystem, Foster City, CA)
in a ﬁnal reaction volume of 10 ml containing 5 ml SybrGreen
universal polymerase chain reaction (PCR) Master Mix (Bio-
Rad, Richmond, CA) and 6 mM primer mix (forward and
reverse). Cycle threshold (CT) values for individual reactions
were determined using ABI Prism-SDS 2.2 data processing
software (Applied Biosystem, Foster City, CA). The CT values
were normalized to GAPDH as a reference gene using the DCT
method, normalizing for the expression of the reference gene
and related to the control treatment. All cDNA samples were
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ampliﬁed in duplicate. Primer sequences for quantitative real-
time reverse transcriptase–PCR (RT-qPCR) are listed in Table 1.
Lentivirus Transduction
For lentiviral transductions to obtain the NOTCH2 knockdown,
HEK cells were transfected using Endofectin-Lenti (Gene
Copoeia, Rockville, MD, EFL-1001-01) with the following plas-
mids: pLKO.1-SH-NOTCH2 (GE-Healthcare Bio-Science, SE, Swe-
den) or pLKO.1-SCR, pVSV-G (envelope plasmid) and
pCMVDR8.91 (gag–pol second generation packaging plasmid).
A combination of ﬁve constructs was tested to improve the
chance of downregulation. For NOTCH2, two constructs were
proven to efﬁciently knock down NOTCH2 by eightfold at pro-
tein level. Virus collection was started the day after transfec-
tion. ASC (50% conﬂuent) were transduced in DMEM, 10%
FBS, supernatant containing viruses were added for two con-
secutive days. The ﬁrst transduction was facilitated with 4 mg/
ml polybrene. Transduced cells were allowed to proliferate for
another 3 days and were then selected with 2 mg/ml puromy-
cin for at least 7 days. Transduction efﬁciency for NOTCH2
(reduced detectable protein by Western blotting analyses)
was conﬁrmed for all NOTCH2 knockdown cultures used in
the experiments.
Vessel Network Formation Two Dimensions and Three
Dimensions
ASC were plated on 15 mm Termanox coverslips (NUNC, Roch-
ester, NY) at 1 3 104/cm2 in DMEM, 10% FBS for 24 hours.
Next, medium was replaced with ECM for 5 days. HUVEC
were seeded on top of ASC monolayers or on gelatin-coated
coverslips at 1 3 104/cm2 in ECM and cultured for 5 days,
after which vascular network formation was assessed. Three-
dimensional (3D) cocultures were achieved by embedding ASC
and HUVEC (3 3 105 cells of each cell population) in 100
ll of Matrigel (Corning, growth factor reduced, New York, NY)
accommodated in a 3D printed scaffold (the scaffold was
printed with a commercially available 3D printer; Reprap
Prusa i3, Anet 3D, China; biodegradable material, polylactic
acid, was used to print the scaffolds). Cells were grown for 9
days. HUVEC tubular formation and interconnection were
assessed at 24 hours, 27 hours, 6 days, and 9 days. Immunos-
taining was performed as following. Samples were ﬁxed in 4%
paraformaldehyde in PBS for 20 minutes. Subsequently, cells
were permeabilized with 1% BSA and 0.5% Triton-X100 in PBS
at room temperature for 1 hour at 48C. After PBS washes, pri-
mary antibodies were incubated for 90 minutes: mouse-anti-
human-CD31 (1:100, Dako, Glostrup, Denmark), rabbit-anti-
human-NOTCH2 (Cell Signaling, Danvers, MA, 4530S). Samples
were washed with PBS and incubated with the ﬂuorescein-
conjugated-donkey-anti-mouse-IgG (for CD31, PECAM-1)
(1:500, Jackson Immunoresearch, U.K.) and to ﬂuorescein-
conjugated-goat-anti-rabbit IgG (for NOTCH2) (1:500, Jackson
Immunoresearch, U.K.) in PBS containing 40,6-diamidino-2-
phenylindole (DAPI). For colocalization staining in both two
dimensions (2D) and 3D, ASC were CM-DiI-labeled (Thermo
Fisher Scientiﬁc, Vybrant CM-DiI red Molecular Probes, Sanbio,
Uden, The Netherlands), whereas HUVEC were staining for
CD31. 2D VNF images were acquired by automated micro-
scope TissueFAXS. Confocal microscope (SP8) was used to
acquire z-stack images at 363. Post-processing for imaging
was achieved using ImageJ free software [28]. 3D scaffolds
were designed with SketchUp 2016 software. 3D VNF were
reconstructed by imageJ 3D viewer plugin.
Immunoblotting
Cells were lysed in radioimmunoprecipitation assay buffer
(RIPA buffer) (Thermo Fisher Scientiﬁc, Waltham, MA), freshly
supplemented with proteinase inhibitor cocktail and phospha-
tase inhibitor cocktails-2 and 3 (all from Sigma-Aldrich, St.
Louis, MO). A total of 10 mg of protein per sample was loaded
in each lane. Electrophoresis was performed in 10% polyacryl-
amide gels, followed by electrotransfer onto nitrocellulose
membranes (Corning with semidry Transblot Turbo system
(Bio-Rad). Membranes were blocked with Odyssey Blocking
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Buffer (Li-COR Biosciences, Lincoln, NE) diluted 1:1 in Tris-
buffered Saline (TBS) at room temperature for 1 hour.
Blots were then incubated with primary antibodies at 48C,
overnight, and after washing with TBS, with secondary anti-
bodies at room temperature for 1 hour. The membranes were
washed three times with TBS with 0.1% Tween in between
incubations and additionally with TBS before the scanning.
Visualization of bound secondary antibodies was done with
an Odyssey scanner (Li-COR Biosciences, Lincoln, NE) and digi-
tal images were captured. These were analyzed with Odyssey
software (Li-COR Biosciences, Lincoln, NE), and densitometry
was performed with TotalLab 120 software (Nonlinear Dynam-
ics, Newcastle, U.K.). Images depicted in ﬁgures were proc-
essed in Adobe Photoshop and Illustrator, and if necessary,
brightness of a whole image was adjusted in linear fashion for
display purposes only (Adobe Systems Incorporated, San Jose,
CA).
The following antibodies were used: Rabbit NOTCH2
(1:1,000, Cell Signaling, Danvers, MA, 4530S), Rabbit platelet-
derived growth factor receptor beta (PDGFRB) (1:250, Santa
Cruz Biotechnology, Dallas, TX, sc-432), Mouse monoclonal
GAPDH (1:1,000, Abcam, Cambridge, U.K., ab9485 or ab9484),
anti-rabbit IgG IRDye-680LT (1:10,000, Li-COR Biosciences, Lin-
coln, NE, 92668021).
Migration Assay
Migration toward chemoattractant PDGF-BB (Recombinant
human PDGF-BB, Peprotech, Inc., NJ), as well as to condi-
tioned media of HUVEC and BREC was measured using a 48-
well micro chemotaxis chamber with 8 mm pore size ﬁlters
(Neuro probe, MD). A concentration of 20 ng/ml PDGF-BB
proved optimal for migration and was used in further experi-
ments. HUVEC and BREC were cultured in RPMI. Twenty-four
hours later, medium was collected and ﬁltered with a 20 mm
ﬁlter (Corning, New York). The lower chamber contained RPMI
supplemented with PDGF-BB, HUVEC and BREC conditioned
medium, 8 3 103 cultured ASC, ASC SH-SCR [Scramble] and
ASC SH-NOTCH2 were placed in the upper chamber. After
incubation at 378C for 4 hours, migrated cells were ﬁxed and
stained with DAPI (Sigma, MO). Nuclei were counted in repre-
sentative high power ﬁelds (12 chemotaxis chambers were
quantiﬁed per condition, n5 3 independent experiments)
visualized with 340 objective magniﬁcation per sample.
Adhesion Assays
Single cell suspensions of ASC were seeded on conﬂuent
monolayers of HUVEC and monitored respectively for 8 hours
(adhesion) and 36 hours (adhesion and proliferation). CM-DiI
labeled ASC (Thermo Fisher Scientiﬁc, Vybrant CM-DiI Molecu-
lar Probes, Sanbio, Uden, The Netherlands) were used to dis-
criminate ASC from HUVEC. At the end of the incubation, the
cocultures were gently washed and ﬁxed with 4% paraformal-
dehyde in PBS for 20 minutes. Nuclei were stained with DAPI.
Stained nuclei and adhered red-labeled ASC were counted
using an automated microscope TissueFAXS (TissueGnostics,
Vienna, Austria).
Proliferation Assay
ASC (WT, SH-SCR, and SH-NOTCH2) were cultured in RPMI
medium until conﬂuency. Twenty-four hours after replacing
fresh RPMI, medium was collected and ﬁltered with a 20 mm
ﬁlter (Corning, New York). HUVEC were seeded at 1 3 104
cells/cm2 and allowed to attach for 2 hours before condi-
tioned medium was added. After 3 days with ASC conditioned
medium treatment, HUVEC were stained with a marker for
proliferative cells (Anti-Ki67 antibody ab15580, 1:250, Abcam).
Four ﬁeld of views from four replicates per condition were
quantiﬁed. ImageJ software was used to split colors. The
images displaying Ki67 staining were transformed to 8-bit. To
each image a threshold was applied. The pixels’ area of Ki67
positive nuclei was quantiﬁed (n5 3 independent
experiments).
Animals and Oxygen-Induced Retinopathy Model
All animal experiments in this study were approved by the
Institutional Animal Care and Use Committee (Regier-
ungspr€asidium Karlsruhe, Germany) and were performed
according to guidelines of the statement of animal experimen-
tation issued by the Association for Research in Vision and
Ophthalmology (ARVO). C57Bl/6J mice were housed in groups
in cages with free access to standard chow and water under
12 hours light and 12 hours dark rhythm. To study the inﬂu-
ence of ASC on hyperoxic vasoregression and subsequent
hypoxia-driven angiogenesis, newborn mice, female, and male
were used to assess the migration and engraftment of ASC
that were administered intravitreally. Mice at postnatal day 7
were exposed to 75% oxygen atmosphere for 5 days with
their nursing mother, and then returned to room air (an
20% oxygen) at postnatal day 12. Directly after return to
room air, randomly selected mice were intravitreally injected
with either 0.5 ml of PBS containing 7 3 103 ASC (WT, SH-
SCR, and SH-NOTCH2) or 0.5 ml PBS alone as control (Hamil-
ton, Microliter Syringes). At P19, mice were under deep anes-
thesia for ERG analysis and for quantiﬁcation of
neovascularization, subsequently mice eyes were enucleated.
After collection, eyes were either ﬁxed in 4% buffered forma-
lin or snap frozen and stored at 808C for later analysis. Whole
mount retinas from P19 animals were permeabilized by treat-
ment with 1% BSA and 0.5% Triton-X100 in PBS at room tem-
perature for 1 hour. Overnight staining was with FITC- or
TRITC-labeled isolectin-B4 (Sigma, 1:50) at 48C. After PBS
washes, retinas were ﬂatmounted in 50% glycerol and subse-
quently stained for microvasculature with Lectin-FITC (1/70,
Sigma-Aldrich, Saint Louis, MO). Retinal capillaries and CM-
DiI-labeled ASC (red) were acquired with a ﬂuorescence
microscope (Leica BMR, Bensheim, Germany). Alternatively,
confocal laser scanning microscopy was used (Leica TCS SP2
Confocal Microscope, Leica, Wetzlar, Germany) to assess
(co-)localization of Lectin-TRITC-stained microvasculature and
CM-DiI-labeled ASC.
Multifocal Electroretinogram
Multifocal electroretinography was performed as previously
described [29]. The mice were placed in front of the scanning
laser ophthalmoscope device (RETImap, Roland Consult, Bran-
denburg, Germany), with a drift tube linac (DTL) electrode
placed at the cornea. Subcutaneous silver needle electrodes
were positioned at the neck of the mice serving as reference
and ground electrodes. A 90 dpt (dioptrie) contact lens (Volk
Optical, Inc., Mentor, OH) mounted over viscous 2% Methocel
gel (OmniVision GmbH, Puchheim, Germany) was placed on
the eyes of the mice. An array of 19 equally sized hexagons
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was chosen and stimulation was performed using 150 cd/m2
and 1 cd/m2 for the m-sequence with four dark frames in
between the stimuli. An average of eight cycles was used for
the ﬁnal analyses. Multifocal electroretinogram (mfERG)
recording took place under photopic conditions where, in
mice, both rod and cone photoreceptors were activated. The
initial negative-going a-wave is initiated by photoreceptors,
whereas the following positive-going b-wave is generated in
the inner retina, mainly by ON-bipolar cells.
Statistical Analysis
All the data are presented as a mean with SD and were ana-
lyzed using GraphPad Prism 5 (GraphPad Software, Inc.). Statis-
tical signiﬁcance was determined using either one-way analysis
of variance (ANOVA) with Bonferroni post hoc or Student’s t
test analysis depending on the experimental conditions. Values
of p< .05 were considered statistically signiﬁcant.
RESULTS
Assessment of Notch Components Expression by ASC
The Notch family comprises ﬁve ligands and four receptors in
mammals. We characterized their basal gene expression in ASC
(Fig. 1A), BREC and HUVEC (Fig. 1B, 1C). The expression of
JAG1, JAG2, DLL1, DLL3, and DLL4 was detected in CT values
not greater than 0.1 in ASC. In contrast, gene expression of the
Notch receptors varied in ASC. NOTCH2 had the highest expres-
sion (CT value 0.2516 0.09 normalized to GAPDH), followed by
NOTCH1 (0.1736 0.006), and NOTCH3 (0.1176 0.003) while
NOTCH4 had either very low expression levels or was not
detectable depending on the ASC donor pool that was
assessed.
The expression levels of JAG1, JAG2, DLL1, DLL4 ligands
and NOTCH2, NOTCH3, and NOTCH4 receptors were all similar
in HUVEC when compared with one another. Expression of
DLL3 was not detectable, while NOTCH1 had the highest
expression (0.2486 0.033). In contrast, in BREC, expression of
JAG1 was highest (0.2476 0.043) compared to JAG2
(0.0686 0.004). DLL1 expression was not detectable, while
expression of DLL3 and DLL4 was similar to JAG2. NOTCH2
expression by ASC was conﬁrmed at the protein level (Fig.
1D). Besides, NOTCH2 protein was not expressed in HUVEC
(Fig. 1D). Immunohistochemistry on ASC and HUVEC con-
ﬁrmed NOTCH2 in ASC and NOTCH2 absence in HUVEC,
respectively (Fig. 1E, 1F).
The maintenance of ASC in normoglycemic (5 mM glu-
cose) or hyperglycemic medium (25 mM glucose) from isola-
tion onward, did not inﬂuence the expression of JAG1, nor
NOTCH1–4 (Supporting Information Fig. S1), while expression
of NOTCH2 was again higher than expression of the other
members. Therefore, our investigations focused on NOTCH2.
NOTCH2 Downregulation Inhibits ASC’s Capacity to
Sustain Vessel Network Formation in 2D and 3D
The role of Notch signaling in controlling the sprouting of
nascent vessels during angiogenesis is well characterized [30].
The pattern of Notch receptors and ligands expression on EC
and pericytes is a regulated mechanism that controls new ves-
sel development and homeostasis. NOTCH2 receptor expres-
sion on ASC may represent a possible mediator of ASC
pericytic features. In order to test this hypothesis, we
Figure 1. ASC predominantly express NOTCH2. Conﬂuent monolayer of ASC cultured in hyperglycemic conditions were harvested and
messenger RNA isolated. Relative gene expression of Notch members was determined using RT-qPCR in (A) ASC, (B) HUVEC, and (C)
BREC. Gene expression was normalized to the reference gene GAPDH (n5 4). (D): NOTCH2 was detected at protein level by Western
blot in ASC WT and HUVEC. NOTCH2 was detected as a 100 kDa band. Immunoﬂuorescence detection of NOTCH2 protein on (E) cul-
tured ASC and (F) HUVEC. Images are representative for n5 3 replicates. Scale bars: 50 lm. Abbreviations: ASC, adipose tissue-derived
stromal cells; BREC, Bovine retinal endothelial cells; HUVEC, human umbilical cord vein endothelial cells; nd, not detectable; RT-qPCR,
real-time polymerase chain reaction.
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Figure 2. SH-NOTCH2 ASC suppresses endothelial cells network formation in 2D. ASC were lentiviral transduced with SH-NOTCH2 vec-
tor and SH-SCR control vector. ASC were stained for NOTCH2 and ﬂow cytometry was used to measure the changes in surface expres-
sion. Representative FACS plots showing percentage of positive cells, in ASC WT (A) and in ASC SH-NOTCH2 (B). The data are
representative of two independent experiments analyzed with FlowJo V10 software (1 3 104 cells analyzed per experimental condition).
(C): VNF of HUVEC (PECAM-1, green) cultured for fourteen days on (D) ASC WT, (E) ASC SHSCR, and (F) ASC SH-NOTCH2. (G): HUVEC
grown on ASC WT monolayer stained for actin ﬁlaments (phalloidin-FITC, green) and membrane protein PECAM-1 (red). (H): Image proc-
essing for removal of F-actin, using imageJ software. HUVEC interconnected network laying between ASC were extracted from a z-stack
acquisition. (I): Lumen formed by HUVEC cultured on ASC-WT. (J): Detection of NOTCH2 expression in ASC WT-driven HUVEC (PECAM-1)
VNF. Inset (K) high magniﬁcation of NOTCH2 expression in ASC WT supported HUVEC VNF. (L): Detection of NOTCH2 expression in ASC
SH-NOTCH2 supported HUVEC VNF. The panels (D, E) were composed by stitching together 25 high magniﬁcation (340) micrographs
obtained by automated microscopy (TissueFAXS). Each experimental condition had three different ASC donors pooled together. The
images are representative for three independent experiments. Scale bar (D–F) 1 mm, (G–J, L) 20 lm, (K) 10 lm. **, p .01, t test.
Abbreviations: ASC, adipose tissue-derived stromal cells; DAPI, 40,6-diamidino-2-phenylindole; FACS, ﬂuorescence-activated cell sorter;
FITC, ﬂuorescein isothiocyanate; HUVEC, human umbilical cord vein endothelial cells; VNF, vascular(-like) network formation.
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Figure 3. ASC SH-NOTCH2 dynamics in 3D microenvironments. ASC and HUVEC (1 to 2 ratio) at a total density of 3 3 105 cells were
embedded in Matrigel. (A): ASC WT, ASC SH-SCR, and ASC-SH-NOTCH2 were cocultures with HUVEC and monitored for respectively 1, 3,
6, and 9 days. A bright ﬁeld microscope was used to acquire images. Field of view 320 magniﬁcation. (B): HUVEC seeded alone at a
total density of 2 3 105 cells (low) and 3 3 105 cells (high density) were embedded in Matrigel and cultured for 5 days. HUVEC
remained round-shaped and no protrusions indicate of network formation were observed. (C): Three-dimensional reconstruction of
vessel-like network formation of ASC (CM-DiI-labeled, red) and HUVEC (PECAM-1, green). Nuclei were stained with 40,6-diamidino-2-phe-
nylindole (blue). Confocal microscopy with z-stack acquisition was used to reconstruct the image. Scale bar: (A) 100 lm, (B) 400 lm,
and (C) 50 lm. Abbreviations: ASC, adipose tissue-derived stromal cells; HUVEC, human umbilical cord vein endothelial cells.
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investigated the capacity of ASC to support HUVEC vessel for-
mation in 2D and 3D.
A short hairpin against NOTCH2 was lentiviral transduced
in ASC to reduce its expression. The 85% of control ASC
showed surface expression of NOTCH2 (Fig. 2A), while in ASC-
SH-NOTCH2, 44% of cells had no detectable surface expres-
sion and the remainder had a signiﬁcantly reduced surface
expression of NOTCH2 (Fig. 2B). NOTCH2 downregulation in
ASC SH-NOTCH2 is further conﬁrmed at protein level (Fig. 2C).
Conﬂuent monolayers of ASC wild type (ASC WT) and ASC
transduced with a scrambled control (ASC SH-SCR) supported
vascular network formation (VNF) by HUVEC (Fig. 2D, 2E),
corroborating our previous data [31]. Thus, the lentiviral trans-
duction by itself did not affect VNF. HUVEC formed an inter-
connected branched network on the ASC monolayer which
remained stable for at least 14 days. In contrast, monolayers
of ASC reduced NOTCH2 surface expression (SH-NOTCH2) did
not support VNF by HUVEC (Fig. 2F). HUVEC that had precipi-
tated by gravity on the ASC SH-NOTCH2 monolayer at best
formed small clusters rather than tubular networks. However,
lack of contact caused death of most seeded HUVEC (not
shown). Confocal laser scanning microscopy revealed that the
ASC adhered to and wrapped around the tubular structures
formed by the HUVEC (Fig. 2G). By focusing on the focal
plane in which the HUVEC were located (Fig. 2H), the deﬁned
tubular structure of the HUVEC identiﬁed through positive
staining for PECAM-1 (red) could be seen surrounded by the
ASC. By using reconstructed Z-stacks from transversal optical
sections, the tubes were conﬁrmed to harbor a lumen (Fig.
2I). ASC in the vicinity of the HUVEC tubular structures, had
intranuclear expression of NOTCH2, indicating that NOTCH2
was activated in these cells (Fig. 2J). Nuclear translocation
and localization of NOTCH2 is showed in Figure 2K. NOTCH2
was not detected in ASC SH-NOTCH2 monolayers (Fig. 2L).
VNF is a valuable tool to assess vasculogenesis in vitro.
However, this assay is limited in its nature as it is not truly
reﬂective of the 3D environment cells experience in vivo. To
address this limitation the inﬂuence of ASC on vasculogenesis,
this process was investigated in a 3D printed scaffold micro-
environment. The scaffold was used as a biodegradable con-
tainer which allowed the Matrigel to be held in place. ASC
WT, SH-SCR, or SH-NOTCH2 were seeded and cocultured with
HUVEC in Matrigel supported by a 3D printed poly-lactic acid
scaffold and followed for nine days (Fig. 3). Within this time,
ASC WT and ASC-SH SCR supported HUVEC to form an inter-
connected branching network. In contrast and similar to their
performance in 2D, ASC SH-NOTCH2 did not support the for-
mation of networks by co-seeded HUVEC (Fig. 3A). Impor-
tantly, HUVEC alone did not sprout or form networks when
embedded in Matrigel at either a lower or high seeding den-
sity (Fig. 3B, right panel lower density and left panel higher
density, respectively), conﬁrming the important role of ASC in
inducing the vasculogenic process. 3D image reconstruction of
the VNF showed the CD31 (PECAM-1) positive HUVEC (green)
Figure 4. NOTCH2 is required for migration of ASC and their
adhesion to endothelial cells, whereas endothelial cell prolifera-
tion is not affected. Medium containing PDGF-BB, HUVEC secre-
tome, and BREC secretome was collected. ASC were cultured
with standard medium and a neuroprobe system was used to
measure ASC migration toward conditioned medium (A) ASC (WT,
SH-SCR, and SH-NOTCH2) migration toward PDGF-BB as well as
conditioned medium derived from BREC and HUVEC (B) Adhesion
of ASC (WT, SH-SCR, and SHNOTCH2) on endothelial cells mono-
layer after 8 hours. (C): ASC (WT, SH-SCR, and SH-NOTCH2) condi-
tioned medium was collected. Proliferation of endothelial cells
treated with ASC conditioned medium was detected by Ki67
staining. ImageJ software was used to split colors. The images dis-
playing Ki67 staining were transformed to 8-bit. To each image, a
threshold was applied. The pixels’ area of Ki67 positive nucleus
were quantiﬁed (n5 3 independent experiments). *, p .05, **,
p .01, ***, p .001, unpaired t test and one-way ANOVA.
Abbreviations: ANOVA, analysis of variance; ASC, adipose tissue-
derived stromal cells; BREC, Bovine retinal endothelial cells;
HUVEC, human umbilical cord vein endothelial cells.
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generated tubular structures supported by the ASC (red CM-
DiI label, Fig. 3C).
PDGFRB, Migration and Adhesion Are Reduced in ASC
SH-NOTCH2
To further examine the role of NOTCH2 in the ASC pericytic-
like phenotype, their migratory capacity was investigated.
Conditioned media from cultured HUVEC and BREC were used
as chemoattractant. In addition, PDGF-BB, known to be an
EC-secreted chemoattractant for pericytes, was used as a posi-
tive control. Wild type ASC and ASC SH-SCR migrated toward
PDGF-BB in a similar fashion and also migrated similarly
toward conditioned media of HUVEC or BREC (Fig. 4A). In
contrast, the migration of ASC SH-NOTCH2 was four- to ﬁve-
fold lower toward PDGF-BB or conditioned media of HUVEC
or BREC, compared to either control media (p .01, p .001,
Fig. 4A). In addition to the reduced responsiveness to chemo-
attractant of ASC SH-NOTCH2, their adhesion to HUVEC was
also reduced (Fig. 4B). The adhesion of ASC SH-NOTCH2 was
approximately 30% lower than ASC WT and ASC SH-SCR
(p .5; p .01, Fig. 4B). Yet, knockdown of NOTCH2 did not
inﬂuence other paracrine signaling by ASC: the proliferation
(Ki67) of HUVEC was similar in conditioned media from con-
trol ASC and ASC SH-NOTCH2 (Fig. 4C).
Because ASC SH-NOTCH2 had reduced migration toward
EC-secreted chemoattractants and PDGF-BB, the expression of
the receptor for PDGF (PDGFRB) was determined in ASC.
Expression of PDGFRB was reduced sixfold (p .001, Fig. 5A)
in ASC SH-NOTCH2 compared to ASC WT. At the protein level,
expression of PDGFRB by ASC SH-NOTCH2 was also reduced
when compared to ASC WT or ASC SH-SCR controls (p .5,
Fig. 5B, protein quantiﬁcation Fig. 5C).
ASC SH-NOTCH2 Do Not Acquire Pericytic Position in
the Oxygen-Induced Retinopathy Retinal
Microvasculature, but Maintain Paracrine Pro-
Regenerative Capacity
In order to verify the ﬁndings obtained in vitro, ASC (WT, SH-
SCR, and SH-NOTCH2) were injected in eyes of mice with
oxygen-induced retinopathy (OIR). In this mouse model, pups
are exposed to hyperoxia while the retinal vasculature is still
developing. The subsequent return of pups at room air (an
20% oxygen) prompts excessive pathological angiogenesis
[32]. Control ASC (WT and SH-SCR) and ASC SH-NOTCH2 were
injected intravitreally at P7 immediately after 5 days of hyper-
oxia. Avascular areas in whole mount retinas were quantiﬁed
at P19. Animals which had not received any ASC injection had
large avascular areas in the central retina (Fig. 6A). The
administration of ASC WT, the scrambled control (ASC-SCR),
and SHNOTCH2 largely restored the avascular areas (untreated
animals avascular areas: 50,000 lm2; ASC treated animals
avascular areas: 10,000 lm2). It appeared that the lentiviral
integration by itself reduced the capacity to fully revascularize
the central retina, because a complete central retinal micro-
vasculature reconstitution was not observed (Fig. 6B–6D). To
further assess the functional status of retinal cell layers after
ASC-induced revascularization, mfERG was performed and a-
waves (photoreceptor function) and b-waves (inner retinal
function) were measured in avascular, vascular, and neovascu-
lar areas. With regard to avascular areas, a-waves measured
in ASC WT, ASC SH-SCR, and ASC SH-NOTCH2 showed an
increase in amplitude when compared to untreated eyes
(p .01, Supporting Information Fig. S2A). Subsequently, b-
wave amplitudes measured in the avascular areas showed sig-
niﬁcant increment when ASC WT were injected in the eyes
and compared to ASC untreated animals (p .5, Supporting
Information Fig. S2B). In contrast, ASC SH-SCR and ASC SH-
Figure 5. NOTCH2 knockdown reduces PDGFRB expression on
ASC. Conﬂuent monolayer of ASC (WT, SH-SCR, and SH-NOTCH2)
were lysed with trizol for mRNA isolation and RIPA buffer for pro-
tein isolation. RT-qPCR was performed and immunoblotting were
performed, respectively. (A): Gene expression of PDGFRB. Expres-
sion of GAPDH was used as reference gene for normalization. (B):
Immunoblotting of PDGFRB expression detected as two bands of
respectively 190 kDa and 180 kDa. (C): PDGFRB protein expres-
sion quantiﬁcation in ASC (WT, SH-SCR, and SH-NOTCH2). The
bands obtained were normalized to GAPDH and quantiﬁed by
ImageJ gel analyzer. *, p .05, ***, p .001, t test. Abbrevia-
tions: ASC, adipose tissue-derived stromal cells; PDGFRB, platelet-
derived growth factor receptor beta; RIPA, radioimmunoprecipita-
tion assay; RT-qPCR, Real-Time Polymerase chain reaction.
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NOTCH2 showed no difference among the groups. There were
no differences detected in the a-wave and b-wave amplitudes
measured in the vascular and neovacular zones across the
groups (Supporting Information Fig. S2C–S2F).
Imaging analyses performed on P19 mice retinas showed
that control ASC (Supporting Information Fig. S3, red) were
homogeneously distributed around the microvasculature (green)
in the retina. Control ASC (WT) had adhered to typical pericytic
positions on the retinal capillaries, that is, on branching points
and around capillaries (arrow heads, Supporting Information Fig.
S3). Similarly, ASC SH-SCR controls also adhered at pericytic
positions. In contrast, intravitreally administered ASC SH-
NOTCH2 did not reach the retinal microvasculature, but formed
intravitreal aggregates (Supporting Information Fig. S3).
DISCUSSION
This study demonstrates that Notch signaling is fundamental
for ASC pericytic interaction and therapeutic function in the
context of pathological retinal vasoproliferation. Speciﬁcally,
NOTCH2 is essential for in vitro vascularization and subse-
quent stabilization. In addition, the expression of the Notch
receptors and JAGGED1 ligand were refractory to HG. Both in
vitro and in vivo, NOTCH2 promotes expression of PDGFRB on
ASC which proved crucial for the EC-driven chemoattraction
of ASC. Finally, NOTCH2 does not affect the pro-angiogenic
paracrine function of ASC because in vivo, both ASC WT and
ASC SH-NOTCH2 showed reconstitution of capillary beds.
However, ASC with reduced NOTCH2 expression appeared to
have lost their migratory capacities when introduced in an
ischemic and neo-vascularized retinal microenvironment.
To date, few studies have investigated the molecular
mechanisms that orchestrate ASC and their interaction with
the retinal microvasculature [33, 34]. In contrast, the role of
Notch signaling in angiogenesis is well-established [30]. Bene-
dito et al. [35] concluded that Notch signaling modulates
VEGFR2 and VEGFR3 in different manners in retinal EC. A spe-
ciﬁc Notch receptor was not identiﬁed in this study, however,
Figure 6. ASC SH-NOTCH2 partially recovered avascular area in the retina. Five days old C57BL/6 mice were exposed to 75% of oxygen
for 5 days and then returned to room air (an 20% oxygen). ASC (WT, SH-SCR, and SH-NOTCH2) (7 3 103 cells/0.5 ll) were injected at
day 7. Retina whole mounts were prepared on day 19. Representative whole mount retinas derived from (A) untreated mouse, (B) ani-
mals with injection of WT ASC, (C) mice with injection of ASC SH-SCR, (D) mice with injection of ASC SH-NOTCH2. Avascular area is
marked by a white closed line. (E): Avascular area quantiﬁcation, n5 7 animals per group. Signiﬁcant difference between ASC WT and
ASC SH-SCR compared with untreated animals and ASC SH-NOTCH2. *, p .05, t test. Scale bars: 500 lm. Images are representative of
results seen in n5 7 animals in each group. Abbreviations: ASC, adipose tissue-derived stromal cells; OIR, oxygen-induced retinopathy.
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the overall Notch activity was ablated by gamma secretase
inhibitor. They reported that VEGFR3 activation depends on
both the Notch and VEGFR2-VEGF axis to promote angiogene-
sis on nascent vessels. Notch signaling alone was not sufﬁ-
cient to induce VEGFR2 activation. The latter suggests that
more upstream regulators might be involved in cell-to-matrix
interaction. In the current study, we show that genetic disrup-
tion of NOTCH2 in ASC prevents “docking” of EC to ASC and
vice versa in vitro. Interestingly, in a 3D coculture system,
NOTCH2 proved essential to promote vasculogenic behavior
of HUVEC. The knockdown of NOTCH2 completely abrogated
network formation by HUVEC.
It is well-known that endothelial-secreted PDGF-BB serves
as a request for mural cell support during vasculogenesis and
angiogenesis [36]. Our results show that NOTCH2 regulates
the expression of PDGFRB on ASC, which is a prime chemo-
tactic receptor of mural cells, that is, pericytes [37]. The retina
has a specialized form of the blood brain barrier and the inhi-
bition of PDGFRB signaling in developing murine retinas dis-
rupted transendothelial barriers and caused vascular leakage
[38], very similar to blood-retina barrier (BRB) changes in DR.
This is likely due to the lack of sufﬁcient support by pericytes.
Our experiments demonstrate the importance of NOTCH2
expression in the regulation of PDGFRB and as a consequence
in the regulation of vasculogenesis and angiogenesis. The
migration of ASC toward PDGF-BB but also to secreted factors
from HUVEC and more importantly from retinal EC (BREC)
depended on NOTCH2 signaling. Similarly, the ASC engraft
required NOTCH2 expression and signaling. In fact, we
observed ASC expressing NOTCH2 in the nucleus in the vicin-
ity of the vasculature. The juxtacrine interaction between ASC
and EC depended on NOTCH2 signaling, yet the paracrine
inﬂuence of ASC on EC was not. On one hand, we showed
that the proliferation of EC in vitro was not affected by condi-
tioned medium of ASC SH-NOTCH2. On the other hand, in
vivo, the restoration of avascular areas in OIR retinas, was vir-
tually similar between controls and ASC SH-NOTCH2-injected
animal eyes. However, the latter did not engraft in the retinal
vasculature. The engraftment of ASC WT and accompanied
vascular restoration corroborates ﬁndings of others [39].
Initial a-waves, which are predominantly rod driven in
rodents, were higher in amplitude in avascular areas when
both ASC WT and ASC SH-NOTCH2 were injected compared
with untreated animals. In contrast, there were no differences
in the a-wave amplitude in neovascular and vascular areas.
These data are in agreement with ﬁndings of others [40, 41],
which showed that human bone marrow MSC preferentially
migrate toward sites of injury in the retina. The choice of the
OIR mouse model was important from the perspective of cell
engraftment. In this model the retinal vasculature is still in
development [32], conferring a more accessible microenviron-
ment for exogenous cells’ homing. Notably, the ischemia-
induced retinal neovascularization in this model is not caused
by HG. However, retinal ischemia, pre-retinal neovasculariza-
tion and retinal gliosis, are all reproducible characteristic of
DR applicable to the OIR mouse model [42]. In fact, we dem-
onstrated that ASC SH-NOTCH2, retained the therapeutic
capacities without physically interacting with inner layers of
the retina microvasculature. Whether the latter ﬁnding is
driven by PDGFRB downregulation or another mechanism is
currently unknown. Moreover, positive b-wave generated by
ON-bipolar cells showed signiﬁcantly improved amplitude upon
ASC injection. Speciﬁcally, avascular areas measured upon ASC
WT or ASC SH-NOTCH2 injection, displayed the same order of
improvement in b-wave compared with untreated animals. This
ﬁnding indicates that ASC SH-NOTCH2 secretome inﬂuenced the
retinal microenvironment. This event might be attributed to
either a direct downregulation of NOTCH2 in ASC, or a combina-
torial effect of NOTCH2 downregulation and the impaired reti-
nal microenvironment apply on ASC. Being more in favor of the
latter, these observations suggest a role for both paracrine and
juxtacrine signaling for the proper functioning of ASC in the reti-
nal microenvironment. A summary of the process investigated
in this study showed the importance of retinal chemoattractant
to recruit ASC. Alternatively, ASC juxtacrine signals are equally
fundamental as the paracrine signals in order to adapt to the
retinal microenvironment.
CONCLUSION
Our results demonstrate the intrinsic capacity of ASC to pro-
mote, orchestrate, and sustain endothelial cell networks through
an evolutionary conserved mechanism, namely Notch signaling.
Moreover, the 3D coculture assay showed temporal dynamics of
ASC driven vasculogenesis in vitro. Importantly, Notch compo-
nents on ASC are not affected by HG. The latter combined with
in vivo experiments, suggested that ASC are promising for thera-
peutic intervention in DR but more research is needed to under-
stand the ASC response to signals from the pathological
extracellular microenvironment into the diabetic retina. Finally,
we propose that molecular intervention is fundamental to
improve and understand the ASC regenerative armamentarium.
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